Invesco
GILD icon

Invesco’s Gilead Sciences GILD Stock Holding History

Invesco’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q1 		– Sell
-12,500
Closed -$782K – 3747
2018
Q4 		$782K Hold
12,500
– – ﹤0.01% 3101
2018
Q3 		$965K Buy
+12,500
New +$944K ﹤0.01% 3157

Other funds holding GILD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return

Invesco's GILD Position: Q2 2026 in Review

Invesco reduced its Gilead Sciences (GILD) stake by 4.2% in Q2 2026, selling an estimated $232M and leaving 39,819,151 shares worth $5.03B. The position accounts for 0.4% of the portfolio, ranked #36.

Invesco first reported a position in GILD in Q2 2013 and has held it in 53 quarters since. The position peaked at $5.8B in Q1 2026. 2,283 funds tracked by Wall St. Rank hold GILD as of Q2 2026.

  • Invesco held 39,819,151 shares of Gilead Sciences worth $5.03B as of Q2 2026.
  • Invesco sold 1,761,672 Gilead Sciences shares in Q2 2026, an estimated $232M.
  • Gilead Sciences made up 0.4% of Invesco's portfolio in Q2 2026, its #36 holding.
  • Invesco first reported a position in Gilead Sciences in Q2 2013 and has held it in 53 quarters since.
  • Invesco's Gilead Sciences position peaked at $5.8B in Q1 2026.
  • 2,283 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.

Based on Invesco's 13F filing for Q2 2026, filed 14 Aug 2026.